ZHANG Zengrui, ZAN Qiang, ZHI Liqiang, et al. Efficacy and Safety of Transdermal Scopolamine for Prevention of Nausea and Vomiting After Total Knee Arthroplasty. [J]. 21(11):1298-1301(2021)
DOI:
ZHANG Zengrui, ZAN Qiang, ZHI Liqiang, et al. Efficacy and Safety of Transdermal Scopolamine for Prevention of Nausea and Vomiting After Total Knee Arthroplasty. [J]. 21(11):1298-1301(2021) DOI: 10.14009/j.issn.1672-2124.2021.11.004.
Efficacy and Safety of Transdermal Scopolamine for Prevention of Nausea and Vomiting After Total Knee Arthroplasty
OBJECTIVE: To evaluate the efficacy and safety of the drug by observing the effects of transdermal scopolamine( TDS) on the incidence of nausea and vomiting
improvement of visual analogue scale( VAS) and the first time of postoperative activity out of bed after total knee arthroplasty. METHODS: A total of 97 patients with total knee arthroplasty in department of knee joint of Xi’an Honghui Hospital from Jun. 2019 to Sept. 2021 were extracted to be divided into the study group( TDS
n = 49) and the control group( placebo
n = 48) via the random number table. In both groups
patches were applied behind the patients’ ear 4 h before surgery
and kept for 72 h. All patients were anesthetized with general anesthesia + femoral nerve block
and preoperative education
surgical operation
postoperative rehabilitation
and multi-mode analgesia were performed by the same group of clinicians. The occurrence of nausea and vomiting in from 4 to 24 h
from 24 to 48 h
from 48 to 72 h and 72 h after surgery
improvement of VAS score and the first time of postoperative activity out of bed was recorded and counted by independent observers. RESULTS: The incidence of PONV in the study group was 0. 261 9 times of that in the control group( 95% CI = 0. 105-0. 654
P = 0. 004). The VAS scores of nausea and vomiting were statistically different between the study group and the control group from 4 to 24 h
from 24 to 48 h and from 48 to 72 h after surgery( P <0. 05)
and the study group was lower than the control group. In terms of the first time of postoperative activity out of bed
62. 50%( 30 cases) of patients in the control group and 85. 71%( 42 cases) of patients in the study group could take exercise on the first day after operation
the proportion of patients in the study group was significantly higher than that in the control group
with statistically significant differences( χ~2= 6. 83
P = 0. 009). There was no significant difference in the incidence of adverse dru reactions between two groups( P > 0. 05). CONCLUSIONS: TDS has the positive effects on reducing the incidence of nausea and vomiting after total knee arthroplasty
avoiding the hepatic intestinal first pass effect and stimulation of the gastrointestinal tract during oral administration
prolonging the duration of drug action
being more convenient for administration and discontinuation of drug administration
and having less adverse drug reactions and higher safety.
关键词
全膝关节置换术东莨菪碱透皮贴术后恶心呕吐
Keywords
Total knee arthroplastyTransdermal scopolaminePostoperative nausea and vomiting